IO Biotech, Inc. (IOBT)
USD 0.98
(-2.05%)
USD 0.98
(-2.05%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -140.69 Million USD | -0.64% |
| 2022 | -139.8 Million USD | 33.91% |
| 2021 | -211.53 Million USD | -6112.36% |
| 2020 | -3.4 Million USD | -516.77% |
| 2019 | 817 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -98.59 Million USD | 14.76% |
| 2024 Q1 | -115.66 Million USD | 17.79% |
| 2023 Q2 | -107.32 Million USD | 14.62% |
| 2023 Q4 | -140.69 Million USD | 13.63% |
| 2023 FY | -140.69 Million USD | -0.64% |
| 2023 Q1 | -125.69 Million USD | 10.09% |
| 2023 Q3 | -162.89 Million USD | -51.78% |
| 2022 Q3 | -148.32 Million USD | 11.59% |
| 2022 FY | -139.8 Million USD | 33.91% |
| 2022 Q4 | -139.8 Million USD | 5.75% |
| 2022 Q1 | -185.51 Million USD | 12.3% |
| 2022 Q2 | -167.78 Million USD | 9.56% |
| 2021 Q1 | 3.4 Million USD | 200.0% |
| 2021 FY | -211.53 Million USD | -6112.36% |
| 2021 Q4 | -211.53 Million USD | -1129.76% |
| 2021 Q3 | -17.2 Million USD | 68.58% |
| 2021 Q2 | -54.75 Million USD | -1707.99% |
| 2020 Q1 | 7.84 Million USD | 0.0% |
| 2020 Q4 | -3.4 Million USD | 0.0% |
| 2020 FY | -3.4 Million USD | -516.77% |
| 2019 FY | 817 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -151.518% |
| Alkermes plc | -166.73 Million USD | 15.617% |
| Agenus Inc. | 274.13 Million USD | 151.325% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 107.524% |
| Aptorum Group Limited | 1.35 Million USD | 10468.035% |
| Ardelyx, Inc. | 34.51 Million USD | 507.681% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 3387.36% |
| Bicycle Therapeutics plc | -481.46 Million USD | 70.777% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 489.069% |
| ChromaDex Corporation | -24.04 Million USD | -485.076% |
| Chimerix, Inc. | -25.51 Million USD | -451.393% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 2119.194% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -494.243% |
| CRISPR Therapeutics AG | -150.84 Million USD | 6.726% |
| Precision BioSciences, Inc. | -85.41 Million USD | -64.734% |
| Dyadic International, Inc. | -6.37 Million USD | -2105.971% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -783.067% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1935.603% |
| Lantern Pharma Inc. | -21.7 Million USD | -548.285% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -27.287% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -1546.917% |
| Incyte Corporation | -3.17 Billion USD | 95.569% |
| Jaguar Health, Inc. | 29.39 Million USD | 578.715% |
| Novavax, Inc. | -298.29 Million USD | 52.832% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 2736.294% |
| Opthea Limited | 28.15 Million USD | 599.687% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -738.043% |
| ContextLogic Inc. | -232 Million USD | 39.354% |
| MiMedx Group, Inc. | -33.9 Million USD | -315.029% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1480.078% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -5972.394% |
| NextCure, Inc. | -6.47 Million USD | -2072.287% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -178.606% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -2105.659% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1256.753% |
| Vaxcyte, Inc. | -368.22 Million USD | 61.79% |
| PDS Biotechnology Corporation | -32.7 Million USD | -330.155% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 914.325% |
| Pharming Group N.V. | 109.8 Million USD | 228.136% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -708.801% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 19.706% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -659.72% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -659.72% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -1881.676% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -2301.007% |
| Acelyrin, Inc. | -216.9 Million USD | 35.133% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -2407.884% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -8061.195% |
| Summit Therapeutics Inc. | 34.67 Million USD | 505.777% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -1968.191% |
| Senti Biosciences, Inc. | 1.74 Million USD | 8186.149% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 23.785% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -81.662% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -2221.0% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 141124.767% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 22504.299% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -20.208% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 16.367% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 226.904% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -1752.278% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -8.973% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 2140.714% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 41.947% |
| Immix Biopharma, Inc. | -17.5 Million USD | -703.545% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 55.574% |
| MEI Pharma, Inc. | -3.7 Million USD | -3697.544% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1224.602% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 186.99% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 606.239% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1935.603% |
| Precigen, Inc. | -481 Thousand USD | -29151.351% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1099.212% |
| AlloVir, Inc. | -62.69 Million USD | -124.429% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -152.992% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 328.163% |
| ImmuCell Corporation | 10.99 Million USD | 1380.18% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 8.724% |
| Onconetix, Inc. | 5.33 Million USD | 2739.045% |
| PureTech Health plc | -167.19 Million USD | 15.848% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -361.914% |
| Elevation Oncology, Inc. | -19.11 Million USD | -635.95% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -2766.144% |
| Seer, Inc. | -4.24 Million USD | -3218.373% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -485.343% |
| Innoviva, Inc. | 255.56 Million USD | 155.055% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -151.86% |
| ESSA Pharma Inc. | -33.62 Million USD | -318.478% |
| GlycoMimetics, Inc. | -40.98 Million USD | -243.299% |
| GT Biopharma, Inc. | -1.02 Million USD | -13680.509% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -107.573% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 329.686% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -4.937% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -915.437% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -387.32% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -186666.931% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -355.897% |
| Aptose Biosciences Inc. | -8.19 Million USD | -1616.918% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -4396.586% |
| Soligenix, Inc. | -4.95 Million USD | -2741.487% |
| Century Therapeutics, Inc. | 847 Thousand USD | 16711.452% |
| Kura Oncology, Inc. | -20.11 Million USD | -599.369% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -243.789% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -1575.387% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 7823.521% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -4300.97% |
| Autolus Therapeutics plc | -186.59 Million USD | 24.598% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -185.37% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 48.984% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 510.584% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 185.6% |
| GRI Bio, Inc. | -1.79 Million USD | -7742.754% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -1466.273% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -323.066% |
| IGM Biosciences, Inc. | -72.6 Million USD | -93.784% |
| INmune Bio, Inc. | -25.41 Million USD | -453.693% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 193.208% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -177.737% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -765.873% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -4777.04% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 470.114% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -241.627% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 541.27% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 137.227% |
| Verastem, Inc. | -37.27 Million USD | -277.432% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -1450.744% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -171.295% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -829.627% |
| Histogen Inc. | -7.48 Million USD | -1779.244% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -551.179% |
| Surrozen, Inc. | -32.66 Million USD | -330.746% |
| Organovo Holdings, Inc. | -1.5 Million USD | -9236.364% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3247.196% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 842.075% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 5478.402% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 3485.443% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -1578.755% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -223.878% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -865.222% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 55.586% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -19385.777% |
| Apollomics, Inc. | -27.39 Million USD | -413.594% |
| Amarin Corporation plc | -191.04 Million USD | 26.351% |
| Mesoblast Limited | 55.96 Million USD | 351.414% |
| Turnstone Biologics Corp. | -14.58 Million USD | -864.749% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -456.298% |
| Synaptogenix, Inc. | -28.66 Million USD | -390.899% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -14931.944% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 388.72% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -16220.705% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -1836.381% |
| Exelixis, Inc. | -73.05 Million USD | -92.606% |
| Better Therapeutics, Inc. | -860 Thousand USD | -16260.349% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -485.928% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 41.708% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 19214.998% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -1791.59% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 11320.016% |
| Gritstone bio, Inc. | 39.49 Million USD | 456.29% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -67.298% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -5245.422% |
| Avid Bioservices, Inc. | 169.72 Million USD | 182.897% |
| Insmed Incorporated | 721.62 Million USD | 119.498% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -1439.122% |
| MediWound Ltd. | -5.32 Million USD | -2543.724% |
| OmniAb, Inc. | 9.2 Million USD | 1628.838% |
| Alector, Inc. | -35.63 Million USD | -294.812% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 263.659% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -2755.093% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1162.762% |
| Zai Lab Limited | -775 Million USD | 81.845% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 141.315% |
| Aura Biosciences, Inc. | -21.52 Million USD | -553.654% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -70.586% |
| Immunic, Inc. | -45.34 Million USD | -210.32% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 27.18% |
| Veracyte, Inc. | -203.82 Million USD | 30.97% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 122.043% |
| FibroGen, Inc. | 56.76 Million USD | 347.854% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1680.0% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -4876.828% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -6695.911% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 103.065% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -4111.284% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 15.223% |
| TG Therapeutics, Inc. | 17.86 Million USD | 887.7% |
| Galecto, Inc. | -21.21 Million USD | -563.174% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -491.545% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 108.965% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -474.939% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1122.725% |
| XBiotech Inc. | -200.02 Million USD | 29.659% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -67.298% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 3207.31% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -298.999% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -82.21% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 2572.307% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 17.437% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -52.315% |
| Vaxxinity, Inc. | 10.13 Million USD | 1488.66% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 119.11% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1206.695% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -113.323% |
| NexImmune, Inc. | -3.13 Million USD | -4389.95% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -3975.075% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -831.075% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -419.185% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -1467.493% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -112843.207% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -246.788% |
| Ainos, Inc. | 4.07 Million USD | 3550.257% |
| Pluri Inc. | 22.82 Million USD | 716.317% |
| Prothena Corporation plc | -608.34 Million USD | 76.872% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -18.477% |
| Celularity Inc. | 65.19 Million USD | 315.829% |
| Rallybio Corporation | -24.1 Million USD | -483.765% |
| Cue Biopharma, Inc. | -33.81 Million USD | -316.035% |
| MeiraGTx Holdings plc | -40.3 Million USD | -249.112% |
| Omeros Corporation | 331.17 Million USD | 142.485% |
| Humacyte, Inc. | -22.48 Million USD | -525.718% |
| Immunocore Holdings plc | -358.59 Million USD | 60.764% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -472.529% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -355.322% |
| Blueprint Medicines Corporation | 702.83 Million USD | 120.019% |
| CalciMedica, Inc. | -5.53 Million USD | -2444.286% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 25.248% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1277.511% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -251.422% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -323.117% |
| Pulmatrix, Inc. | -10.41 Million USD | -1250.667% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -2254.007% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -268.882% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -26.298% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -134.717% |
| Cytokinetics, Incorporated | 642.37 Million USD | 121.903% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -2316.263% |
| Nutriband Inc. | -251.65 Thousand USD | -55809.035% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -312.377% |
| Vor Biopharma Inc. | 4.3 Million USD | 3372.07% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 97.669% |
| Evogene Ltd. | -19.63 Million USD | -616.609% |
| ProKidney Corp. | -56.23 Million USD | -150.194% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -189.076% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1423.18% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 110.316% |
| CorMedix Inc. | -43.05 Million USD | -226.808% |
| BioLineRx Ltd. | 7.33 Million USD | 2017.925% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -412.285% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 404.893% |
| Atai Life Sciences N.V. | -28.55 Million USD | -392.678% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 6407.876% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -516.668% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 893.341% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -87.414% |
| MediciNova, Inc. | -50.78 Million USD | -177.056% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -78.541% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -625367.882% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2080.505% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 29.587% |
| Biomea Fusion, Inc. | -166.57 Million USD | 15.532% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 21.386% |
| Mereo BioPharma Group plc | -51.46 Million USD | -173.366% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -48.348% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 52.104% |
| Absci Corporation | -72.59 Million USD | -93.806% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3181.45% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 39.984% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -49.345% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -47.027% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -260.093% |
| Allakos Inc. | -24.97 Million USD | -463.359% |
| Imunon, Inc. | -4.21 Million USD | -3238.964% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -854.409% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -3.914% |
| BioAtla, Inc. | -109.01 Million USD | -29.069% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 19214.998% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -14883.919% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1275.823% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -563.581% |
| XOMA Corporation | -29 Million USD | -385.169% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -749.632% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -1460.548% |
| aTyr Pharma, Inc. | -7.44 Million USD | -1788.831% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -12.888% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 32.41% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -72.048% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -51.676% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -16275.887% |
| Akari Therapeutics, Plc | -3.84 Million USD | -3559.272% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 8769.657% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 110.189% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -11742.004% |
| UroGen Pharma Ltd. | 4.39 Million USD | 3304.259% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 223.985% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 195618.468% |
| Orgenesis Inc. | 21.78 Million USD | 745.882% |
| Entera Bio Ltd. | -10.62 Million USD | -1223.728% |
| GH Research PLC | -78.07 Million USD | -80.205% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -531.277% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -427.773% |
| Xencor, Inc. | 29.64 Million USD | 574.629% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -7042.763% |
| Replimune Group, Inc. | 1.41 Million USD | 10064.518% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -57349.736% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -11.298% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -11742.004% |
| Portage Biotech Inc. | -4.98 Million USD | -2724.714% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -625367.882% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -112.787% |
| OncoCyte Corporation | -6.56 Million USD | -2043.821% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 15778.289% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -2988.455% |
| Purple Biotech Ltd. | -14.13 Million USD | -895.183% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -492.267% |
| scPharmaceuticals Inc. | -6.54 Million USD | -2049.717% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -742.904% |
| HilleVax, Inc. | -165.48 Million USD | 14.978% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -5443.696% |
| Tharimmune, Inc. | -10.93 Million USD | -1186.644% |
| Genprex, Inc. | -6.73 Million USD | -1988.257% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 61.85% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -59.054% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -9942.755% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -4141.824% |
| OKYO Pharma Limited | -826.84 Thousand USD | -16916.308% |
| Savara Inc. | 153 Thousand USD | 92060.131% |
| Curis, Inc. | -23.88 Million USD | -489.019% |
| Daré Bioscience, Inc. | -5.15 Million USD | -2627.829% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -18031.034% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -2166.414% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 11973.333% |
| BeiGene, Ltd. | -2.25 Billion USD | 93.755% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1240.325% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 76.866% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 24.187% |
| Erasca, Inc. | -37.21 Million USD | -278.061% |
| bluebird bio, Inc. | 108.57 Million USD | 229.592% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -10824.743% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 137.148% |
| DBV Technologies S.A. | -126.98 Million USD | -10.799% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -10824.743% |
| Moderna, Inc. | -2.9 Billion USD | 95.16% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1259.148% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1194.617% |
| Molecular Templates, Inc. | 707 Thousand USD | 20000.849% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -348.5% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 140.593% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -71.455% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -53.384% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -335.979% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -309.294% |
| MacroGenics, Inc. | -66.98 Million USD | -110.046% |
| RenovoRx, Inc. | -1.17 Million USD | -11894.8% |
| Adicet Bio, Inc. | -138.78 Million USD | -1.378% |
| Prime Medicine, Inc. | -27.94 Million USD | -403.557% |
| Aditxt, Inc. | 18.12 Million USD | 876.447% |
| Adagene Inc. | -87.62 Million USD | -60.565% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3277.78% |
| Quantum-Si incorporated | -118.55 Million USD | -18.676% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 490.776% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -1782.465% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -190.047% |
| SciSparc Ltd. | -2.06 Million USD | -6713.511% |
| Vericel Corporation | 1.27 Million USD | 11117.933% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1073.303% |
| Minerva Neurosciences, Inc. | 41 Million USD | 443.133% |
| Generation Bio Co. | 31.44 Million USD | 547.402% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 19.767% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -354.998% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 220.675% |
| Invivyd, Inc. | -198.47 Million USD | 29.11% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -55.865% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -5768.111% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -98.755% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -1961.524% |
| 2seventy bio, Inc. | 181.71 Million USD | 177.428% |
| ADMA Biologics, Inc. | 90.06 Million USD | 256.218% |
| Clene Inc. | 3.34 Million USD | 4312.545% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -1449.087% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -554.079% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2080.505% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 59.114% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -441.157% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 179.193% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -3338.756% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 2912.855% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -2601.075% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -7.977% |
| Evaxion Biotech A/S | 5.28 Million USD | 2761.304% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -24.99% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -7.18% |
| Trevena, Inc. | 2.25 Million USD | 6331.134% |
| Surrozen, Inc. | -32.66 Million USD | -330.746% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -173.149% |
| Cingulate Inc. | 3.08 Million USD | 4664.173% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -4690.569% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 2057.687% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1414.321% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -77.375% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -7.035% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -33.311% |
| Clearmind Medicine Inc. | -3.94 Million USD | -3468.652% |
| Kronos Bio, Inc. | -36.05 Million USD | -290.245% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 1595.366% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 9749.297% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -159.324% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1075.964% |
| ImmunityBio, Inc. | 618.22 Million USD | 122.759% |
| Korro Bio, Inc. | -132.94 Million USD | -5.834% |
| Kineta, Inc. | -4.54 Million USD | -2998.414% |
| BioVie Inc. | -17.73 Million USD | -693.459% |
| Codexis, Inc. | -43.27 Million USD | -225.158% |
| Celularity Inc. | 65.19 Million USD | 315.829% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -4339.855% |
| Celcuity Inc. | 6.78 Million USD | 2174.133% |
| Virax Biolabs Group Limited | -3.36 Million USD | -4081.318% |
| Cibus, Inc. | -8.07 Million USD | -1641.755% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -3227.004% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 3178.753% |
| IN8bio, Inc. | -16.38 Million USD | -758.497% |
| Kodiak Sciences Inc. | -103.87 Million USD | -35.45% |
| Annexon, Inc. | -193.75 Million USD | 27.383% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 390930.556% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -704.04% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -3905.095% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 113.346% |
| Eyenovia, Inc. | 1.25 Million USD | 11278.103% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 622.947% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -4238.545% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -323.193% |
| Arcellx, Inc. | -296.95 Million USD | 52.62% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -621.311% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -138.979% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -578.82% |
| Moolec Science SA | 117.61 Thousand USD | 119725.731% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -266.413% |
| Geron Corporation | 14.76 Million USD | 1053.181% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -271.061% |
| Royalty Pharma plc | 5.65 Billion USD | 102.487% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 0.511% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -1913.027% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -2523.582% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 0.023% |
| Humacyte, Inc. | -22.48 Million USD | -525.718% |
| Structure Therapeutics Inc. | -124.33 Million USD | -13.158% |
| 89bio, Inc. | -289.05 Million USD | 51.324% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -457.4% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -7791.139% |
| Genelux Corporation | -6.89 Million USD | -1939.412% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -353.006% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 268.302% |
| Notable Labs, Ltd. | -9.77 Million USD | -1339.229% |
| Liquidia Corporation | -80.17 Million USD | -75.488% |
| Mustang Bio, Inc. | -3.73 Million USD | -3666.033% |
| Immunovant, Inc. | -635.22 Million USD | 77.851% |
| Quantum-Si incorporated | -118.55 Million USD | -18.676% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -701.065% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -3296.066% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 1852.822% |
| Acasti Pharma Inc. | -23 Million USD | -511.602% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -4078.48% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -765.873% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -2.148% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -4414.848% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -532.867% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -657.709% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 16.883% |
| PepGen Inc. | -60.67 Million USD | -131.909% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -512.374% |
| United Therapeutics Corporation | -507.7 Million USD | 72.287% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -635.643% |
| Solid Biosciences Inc. | -47.75 Million USD | -194.658% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -16220.705% |
| Immuneering Corporation | -54.94 Million USD | -156.082% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3247.196% |
| Silo Pharma, Inc. | -3.52 Million USD | -3892.245% |
| Belite Bio, Inc | -87.27 Million USD | -61.221% |
| XOMA Corporation | -29 Million USD | -385.169% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -99.017% |
| Bionomics Limited | 227 Million USD | 161.979% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -20.998% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -5454.639% |
| uniQure N.V. | -102.95 Million USD | -36.666% |
| Cassava Sciences, Inc. | -121.13 Million USD | -16.15% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3277.78% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 443.579% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1076.315% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -4447.185% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 132834.906% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -4238.545% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1680.0% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -1797.236% |
| Altimmune, Inc. | -134.48 Million USD | -4.619% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 171.037% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -5454.639% |
| Compugen Ltd. | -12.9 Million USD | -990.352% |
| Peak Bio, Inc. | 10.34 Million USD | 1460.705% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -49616.961% |
| Benitec Biopharma Inc. | -50.58 Million USD | -178.16% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -34.849% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 816.208% |
| Zura Bio Limited | -99.8 Million USD | -40.972% |
| PolyPid Ltd. | 6.17 Million USD | 2380.373% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 289.826% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 816.208% |
| Instil Bio, Inc. | 75.35 Million USD | 286.707% |
| argenx SE | -2.02 Billion USD | 93.065% |
| Immunome, Inc. | -97.02 Million USD | -45.007% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -525.468% |
| Verona Pharma plc | -220.44 Million USD | 36.174% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -96.115% |
| Shattuck Labs, Inc. | -121.42 Million USD | -15.874% |
| CervoMed Inc. | -7.79 Million USD | -1705.489% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 24.151% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -3117.448% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -6.801% |
| Moolec Science SA | 117.61 Thousand USD | 119725.731% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -6049.494% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 984.99% |
| AnaptysBio, Inc. | -18.15 Million USD | -675.158% |
| Design Therapeutics, Inc. | -18.15 Million USD | -675.201% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -99.91% |
| NeurAxis, Inc. | 145.7 Thousand USD | 96667.605% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1352.662% |
| Lumos Pharma, Inc. | -28.49 Million USD | -393.802% |
| Achilles Therapeutics plc | -126.92 Million USD | -10.853% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -96.115% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -21356.85% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -577.29% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 9749.297% |
| Nutriband Inc. | -251.65 Thousand USD | -55809.035% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -968.248% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -1791.116% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 141.358% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 692.791% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 68.557% |
| Palisade Bio, Inc. | -12.06 Million USD | -1066.368% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -0.277% |
| Beam Therapeutics Inc. | -262.72 Million USD | 46.446% |
| Neurogene Inc. | -131.95 Million USD | -6.627% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 744.935% |
| AEON Biopharma, Inc. | -4.88 Million USD | -2783.176% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 62.698% |
| Sesen Bio, Inc. | -112.55 Million USD | -25.007% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -40.896% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -5892.82% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -260.526% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -68.943% |
| Athira Pharma, Inc. | -88.99 Million USD | -58.091% |
| Vaccinex, Inc. | -1.28 Million USD | -10823.835% |
| HCW Biologics Inc. | 2.85 Million USD | 5025.27% |
| XOMA Corporation | -29 Million USD | -385.169% |
| Nektar Therapeutics | 210.24 Million USD | 166.923% |
| Arvinas, Inc. | -313.8 Million USD | 55.163% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 8769.657% |
| Merus N.V. | -192.88 Million USD | 27.055% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 334.557% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -1927.948% |
| Rezolute, Inc. | -68.16 Million USD | -106.4% |
| Clene Inc. | 3.34 Million USD | 4312.545% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -966.952% |
| BeyondSpring Inc. | -13.75 Million USD | -922.893% |
| Synlogic, Inc. | -6.68 Million USD | -2004.697% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 12507.319% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -1564.092% |
| Peak Bio, Inc. | 10.34 Million USD | 1460.705% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -70.71% |
| Krystal Biotech, Inc. | -350.23 Million USD | 59.827% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 213.353% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 16.744% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -4356.528% |
| MannKind Corporation | 143.89 Million USD | 197.776% |
| Ikena Oncology, Inc. | -109.15 Million USD | -28.897% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -1758.394% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -325.073% |
| Gossamer Bio, Inc. | 180.35 Million USD | 178.012% |
| CohBar, Inc. | -5.93 Million USD | -2272.372% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -372.97% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3181.45% |
| Legend Biotech Corporation | -949.39 Million USD | 85.18% |
| Mural Oncology plc | -255.84 Million USD | 45.006% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 536.75% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -2886.833% |
| Disc Medicine, Inc. | -358.28 Million USD | 60.729% |
| Champions Oncology, Inc. | 4.81 Million USD | 3023.919% |
| REGENXBIO Inc. | 54.76 Million USD | 356.9% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -52222.55% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 6.837% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -1461.24% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -74.385% |
| Vaxart, Inc. | -8.24 Million USD | -1607.305% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -180.389% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -10.642% |
| Cellectis S.A. | -43.85 Million USD | -220.828% |
| Longeveron Inc. | -2.9 Million USD | -4738.343% |
| Repare Therapeutics Inc. | -107.85 Million USD | -30.448% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 114.529% |
| Inozyme Pharma, Inc. | 12 Million USD | 1272.101% |
| Revolution Medicines, Inc. | -608.2 Million USD | 76.866% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -11338.943% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 46.929% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 6.246% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -799.208% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -18913.378% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.529% |
| Denali Therapeutics Inc. | -74.86 Million USD | -87.937% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1073.303% |
| Veru Inc. | 4.77 Million USD | 3043.513% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1151.103% |
| Cingulate Inc. | 3.08 Million USD | 4664.173% |
| Passage Bio, Inc. | 4.58 Million USD | 3168.68% |
| Context Therapeutics Inc. | -14.44 Million USD | -873.707% |
| Exicure, Inc. | 5.84 Million USD | 2505.522% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 38.926% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -255.57% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 996.686% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -139.199% |
| Nuvalent, Inc. | -335.38 Million USD | 58.049% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 8212.534% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -88.903% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -1482.666% |
| OmniAb, Inc. | 9.2 Million USD | 1628.838% |
| Anew Medical, Inc. | 1.43 Million USD | 9922.16% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 958.876% |
| Lipocine Inc. | -4.75 Million USD | -2859.223% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -28.108% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1023.767% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -177.737% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 665.238% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -1993.424% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -113.741% |
| Ocugen, Inc. | -32.52 Million USD | -332.64% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -64.416% |
| Q32 Bio Inc. | -37.94 Million USD | -270.768% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -22304.299% |
| Alumis Inc. Common Stock | -13.52 Million USD | -939.981% |
| Equillium, Inc. | -22.39 Million USD | -528.345% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -450.293% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -331.238% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -56652.919% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 204.966% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 4499.593% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 42938.44% |
| Dominari Holdings Inc. | 195 Thousand USD | 72253.333% |
| Edesa Biotech, Inc. | -5.26 Million USD | -2571.377% |
| vTv Therapeutics Inc. | -8.91 Million USD | -1477.874% |
| Bio-Techne Corporation | 267.74 Million USD | 152.549% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -768.03% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -19.142% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -1574.39% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1012.157% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 42.6% |
| Nkarta, Inc. | 57.29 Million USD | 345.552% |
| BioCardia, Inc. | 212 Thousand USD | 66467.453% |
| Iterum Therapeutics plc | 13.43 Million USD | 1147.023% |